Organization | Federal University of Paraiba

Federal University of Paraiba Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4

Founded: Joao Pessoa Brazil (1955)

Organization Overview

First Clinical Trial

2006

NCT00875212

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Alternative names

Federal Univerisity of Paraiba | Federal University fo Paraiba | Federal University of Paraiba | Federal University of Paraíba | Thamires Ribeiro Chaves | UFPB | UFPB Paraíba Federal University | University Federal of Paraiba

Active Ingredients

Drugs in Phase 4 Trials (4)

dexmedetomidine (precedex) (1 trial)

methyldopa (aldomet) (1 trial)

sodium chloride (1 trial)

sodium fluoride (4 trials)

Drugs in Phase 2 Trials (7)

denosumab (prolia) (1 trial)

ethanol (1 trial)

folic acid (2 trials)

glyburide (micronase) (1 trial)

pregabalin (lyrica) (1 trial)

schinus terebinthifolius (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 1 Trials (1)

calcium glycerylphosphate (1 trial)

Drugs in Other Trials (4)

green tea (1 trial)

hazelnut oil (1 trial)

starch (1 trial)

vitamin e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dental Caries (Phase 4)

Diabetes Mellitus (Phase 2)

Fluoride Poisoning (Phase 4)

Fluorosis, Dental (Phase 4)

Gingivitis (Phase 2)

Overweight (Phase 2)

Pain, Postoperative (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 15
# of Trial APIs: 16